Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bettina Hofmann

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Basic & Clinical Pharmacology & Toxicology|August 20, 2013
Recent advances in the search for novel 5-lipoxygenase inhibitorsDieter Steinhilber, Bettina Hofmann
Expert Opinion on Therapeutic Patents|April 23, 2013
5-Lipoxygenase inhibitors: a review of recent patents (2010-2012)Bettina Hofmann, Dieter Steinhilber
European Journal of Medicinal Chemistry|December 3, 2014
Development and evaluation of ST-1829 based on 5-benzylidene-2-phenylthiazolones as promising agent for anti-leukotriene therapyAndreas P Lill, Carmen B Rödl, Dieter Steinhilber, et al.
European Journal of Pharmacology|February 26, 2009
MK-886, an inhibitor of the 5-lipoxygenase-activating protein, inhibits cyclooxygenase-1 activity and suppresses platelet aggregationAndreas Koeberle, Ulf Siemoneit, Hinnak Northoff, et al.
Journal of Computational Chemistry|August 30, 2008
PhAST: pharmacophore alignment search toolVolker Hähnke, Bettina Hofmann, Tomislav Grgat, et al.
Bioorganic & Medicinal Chemistry|May 4, 2012
Synthesis and biological evaluation of a class of 5-benzylidene-2-phenyl-thiazolinones as potent 5-lipoxygenase inhibitorsSebastian Barzen, Carmen B Rödl, Andreas Lill, et al.
The FEBS Journal|May 27, 2014
Analysis of 5-lipoxygenase phosphorylation on molecular level by MALDI-MSStavroula Markoutsa, Duran Sürün, Michael Karas, et al.
Chemmedchem|August 9, 2008
Scaffold-hopping cascade yields potent inhibitors of 5-lipoxygenaseBettina Hofmann, Lutz Franke, Ewgenij Proschak, et al.
Bioorganic Chemistry|January 10, 2020
4-(4-Chlorophenyl)thiazol-2-amines as pioneers of potential neurodegenerative therapeutics with anti-inflammatory properties based on dual DNase I and 5-LO inhibitionAndrija Smelcerovic, Aleksandra Zivkovic, Budimir S Ilic, et al.
Chemmedchem|April 21, 2011
Potent inhibitors of 5-lipoxygenase identified using pseudoreceptorsCarmen B Rödl, Yusuf Tanrikulu, Joanna M Wisniewska, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Basic & Clinical Pharmacology & Toxicology|August 20, 2013
Recent advances in the search for novel 5-lipoxygenase inhibitorsDieter Steinhilber, Bettina Hofmann
Expert Opinion on Therapeutic Patents|April 23, 2013
5-Lipoxygenase inhibitors: a review of recent patents (2010-2012)Bettina Hofmann, Dieter Steinhilber
European Journal of Medicinal Chemistry|December 3, 2014
Development and evaluation of ST-1829 based on 5-benzylidene-2-phenylthiazolones as promising agent for anti-leukotriene therapyAndreas P Lill, Carmen B Rödl, Dieter Steinhilber, et al.
European Journal of Pharmacology|February 26, 2009
MK-886, an inhibitor of the 5-lipoxygenase-activating protein, inhibits cyclooxygenase-1 activity and suppresses platelet aggregationAndreas Koeberle, Ulf Siemoneit, Hinnak Northoff, et al.
Journal of Computational Chemistry|August 30, 2008
PhAST: pharmacophore alignment search toolVolker Hähnke, Bettina Hofmann, Tomislav Grgat, et al.
Bioorganic & Medicinal Chemistry|May 4, 2012
Synthesis and biological evaluation of a class of 5-benzylidene-2-phenyl-thiazolinones as potent 5-lipoxygenase inhibitorsSebastian Barzen, Carmen B Rödl, Andreas Lill, et al.
The FEBS Journal|May 27, 2014
Analysis of 5-lipoxygenase phosphorylation on molecular level by MALDI-MSStavroula Markoutsa, Duran Sürün, Michael Karas, et al.
Chemmedchem|August 9, 2008
Scaffold-hopping cascade yields potent inhibitors of 5-lipoxygenaseBettina Hofmann, Lutz Franke, Ewgenij Proschak, et al.
Bioorganic Chemistry|January 10, 2020
4-(4-Chlorophenyl)thiazol-2-amines as pioneers of potential neurodegenerative therapeutics with anti-inflammatory properties based on dual DNase I and 5-LO inhibitionAndrija Smelcerovic, Aleksandra Zivkovic, Budimir S Ilic, et al.
Chemmedchem|April 21, 2011
Potent inhibitors of 5-lipoxygenase identified using pseudoreceptorsCarmen B Rödl, Yusuf Tanrikulu, Joanna M Wisniewska, et al.
Pageof 5